1. Abolition of solid tumors and their metastases by intra-tumoral alpha radiation in combination with CpG and inhibitors of immune suppressor cells. (July 2016) Authors: Keisari, Y.; Confino, H.; Scmidt, M.; Efrati, M.; Umansky, V.; Kelson, I. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0218: Approximate modeling for dose calculations in Diffusing Alpha-emitters Radiation Therapy. (November 2020) Authors: Arazi, L.; Dumančić, M.; Keisari, Y.; Kelson, I. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-0960: Radiobiological effectiveness and its role in modelling secondary cancer risk for proton therapy. (May 2017) Authors: Keisari, Y.; Etzyoni, R.; Bittan, H.; Lazarov, E.; Efrati, M.; Schmidt, M.; Cooks, T.; Arazi, L.; Kelson, I. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0961: DNA damage and repair influence tumor sensitivity to diffusing alpha emitters radiation therapy. (May 2017) Authors: Keisari, Y.; Etzyoni, R.; Bittan, H.; Lazarov, E.; Efrati, M.; Schmidt, M.; Cooks, T.; Arazi, L.; Kelson, I. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-1033: Activation of specific anti-tumor immunity by alpha radiation based brachytherapy and immunotherapy. (April 2018) Authors: Keisari, Y.; Cohen, A.; Efrati, M.; Schmidt, M.; Galalae, R.; Kelson, I. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-190: Local and systemic abolition of metastatic cancer by alpha particle brachytherapy and immunotherapy. (December 2019) Authors: Keisari, Y.; Domankevich-Bachar, V.; Cohen, A.; Efrati, M.; Bellia, S.R.; Feliciani, G.; Monti, M.; Schmidt, M.; Kelson, I. Journal: Radiotherapy and oncology Issue: Volume 141(2019)Supplement 1 Page Start: S84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Treatment of squamous cell carcinoma by alpha-radiation based brachytherapy (alpha dart), a new radiation concep. (May 2019) Authors: Rosenfeld, E.; Mizrachi, A.; Ben-Hur, R.; Keisari, Y.; Kelson, I.; Popovtzer, A. Journal: International journal of oral & maxillofacial surgery Issue: Volume 48(2019)Supplement 1 Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment of squamous cell carcinoma by alpha-radiation based brachytherapy (alpha dart), a new radiation concept. (May 2019) Authors: Rosenfeld, E.; Mizrachi, A.; Ben-Hur, R.; Keisari, Y.; Kelson, I.; Popovtzer, A. Journal: International journal of oral & maxillofacial surgery Issue: Volume 48(2019)Supplement 1 Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗